Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert Maertens

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Personalized Medicine|May 23, 2018
GENimmune NVGeert Maertens, Lydie Meheus, Fred Shapiro, et al.
Methods in Molecular Medicine|February 26, 2004
Hepatitis B viral genotyping with the research INNO-LiPA HBV genotyping line probe assaySija De Gendt, Fred Shapiro, Jelena Juras, et al.
The Journal of General Virology|June 21, 2002
Detection of neutralizing antibodies to hepatitis C virus using a biliary cell infection modelSaadia Bichr, Rosanna Rende-Fournier, Giovanna Vona, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|May 9, 2002
Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alphaCosme Alvarado Esquivel, André Elewaut, Jan Philippé, et al.
Vaccine|August 7, 2004
A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteersGeert Leroux-Roels, Erik Depla, Frank Hulstaert, et al.
Cancers|July 24, 2021
Characterization and Clinical Utility of <i>BRAF</i><sup>V600</sup> Mutation Detection Using Cell-Free DNA in Patients with Advanced MelanomaPiotr Rutkowski, Patrick Pauwels, Joseph Kerger, et al.
Human Vaccines|October 14, 2006
Immunogenicity and tolerability of intradermal administration of an HCV E1-based vaccine candidate in healthy volunteers and patients with resolved or ongoing chronic HCV infectionGeert Leroux-Roels, Arsène-Hélène Batens, Isabelle Desombere, et al.
Melanoma Research|December 5, 2015
Applications for quantitative measurement of BRAF V600 mutant cell-free tumor DNA in the plasma of patients with metastatic melanomaMax Schreuer, Geert Meersseman, Sari van Den Herrewegen, et al.
Journal of Clinical Microbiology|October 2, 2002
Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assayAnna S F Lok, Fabien Zoulim, Stephen Locarnini, et al.
Journal of Hepatology|January 28, 2003
Hepatic immunohistochemical staining with a monoclonal antibody against HCV-E2 to evaluate antiviral therapy and reinfection of liver grafts in hepatitis C viral infectionChris Verslype, Frederik Nevens, Nicoletta Sinelli, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Personalized Medicine|May 23, 2018
GENimmune NVGeert Maertens, Lydie Meheus, Fred Shapiro, et al.
Methods in Molecular Medicine|February 26, 2004
Hepatitis B viral genotyping with the research INNO-LiPA HBV genotyping line probe assaySija De Gendt, Fred Shapiro, Jelena Juras, et al.
The Journal of General Virology|June 21, 2002
Detection of neutralizing antibodies to hepatitis C virus using a biliary cell infection modelSaadia Bichr, Rosanna Rende-Fournier, Giovanna Vona, et al.
Revista De Investigacion Clinica; Organo Del Hospital De Enfermedades De La Nutricion|May 9, 2002
Evolution of hepatitis C virus-specific T cell responses and cytokine production in chronic hepatitis C patients treated with high doses of interferon-alphaCosme Alvarado Esquivel, André Elewaut, Jan Philippé, et al.
Vaccine|August 7, 2004
A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteersGeert Leroux-Roels, Erik Depla, Frank Hulstaert, et al.
Cancers|July 24, 2021
Characterization and Clinical Utility of <i>BRAF</i><sup>V600</sup> Mutation Detection Using Cell-Free DNA in Patients with Advanced MelanomaPiotr Rutkowski, Patrick Pauwels, Joseph Kerger, et al.
Human Vaccines|October 14, 2006
Immunogenicity and tolerability of intradermal administration of an HCV E1-based vaccine candidate in healthy volunteers and patients with resolved or ongoing chronic HCV infectionGeert Leroux-Roels, Arsène-Hélène Batens, Isabelle Desombere, et al.
Melanoma Research|December 5, 2015
Applications for quantitative measurement of BRAF V600 mutant cell-free tumor DNA in the plasma of patients with metastatic melanomaMax Schreuer, Geert Meersseman, Sari van Den Herrewegen, et al.
Journal of Clinical Microbiology|October 2, 2002
Monitoring drug resistance in chronic hepatitis B virus (HBV)-infected patients during lamivudine therapy: evaluation of performance of INNO-LiPA HBV DR assayAnna S F Lok, Fabien Zoulim, Stephen Locarnini, et al.
Journal of Hepatology|January 28, 2003
Hepatic immunohistochemical staining with a monoclonal antibody against HCV-E2 to evaluate antiviral therapy and reinfection of liver grafts in hepatitis C viral infectionChris Verslype, Frederik Nevens, Nicoletta Sinelli, et al.
Pageof 3